Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Echoliv logo — Crafting AI-driven solutions for abdominal ultrasound, provi...

Echoliv

Crafting AI-driven solutions for abdominal ultrasound, providing early-stage screening to detect liver cancer and other nodules often missed by practitioners.

Founded 2021 2-10 employees Pre-Seed Total: $150.00K AI, Biotechnology +1

General Information

Company Name Echoliv
Founded Year 2021
Employees 2-10
Industries AI, Biotechnology, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Echoliv. To contact Echoliv, visit echoliv.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Echoliv compare?

A PDF of Echoliv and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Echoliv soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Echoliv

Echoliv is an AI-driven startup that focuses on abdominal ultrasound imaging, with the aim of providing early-stage screening to detect liver cancer and other nodules often missed by practitioners. The company's flagship product, Ultraliv, utilizes AI algorithms to aid professionals in the early detection of hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. This innovative technology has the capability to identify nodules that may not be visible to practitioners, thereby enhancing the accuracy of diagnoses in this critical medical area. Founded in 2021, Echoliv operates within the AI, Biotechnology, and Health Care industries. The company recently secured a €60.00K Pre Seed Round investment on 07 July 2022 with support from WILCO. Echoliv's groundbreaking approach and promising technological solutions have positioned them as a noteworthy player in the healthcare AI sector, with the potential to significantly impact the early detection and treatment of liver diseases.

Business keywords: AI-driven solutions, abdominal ultrasound imaging, early-stage screening, liver cancer detection, nodules identification, radiologist support, hepatologist support, Ultraliv solution, HCC detection, artificial intelligence software, medical imaging technology, medical diagnostics, health tech

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round €60.00K 1
WILCO
WILCO
07 Jul 2022
Grant €90.00K 1
Bpifrance
Bpifrance
14 Sep 2021

Echoliv Alternatives & Competitors

View All Alternatives
Echoliv vs
AILIS Care
AILIS Care Poland

Breast Cancer Prediction Technology

Grant
21 employees
AI, Health Care
Echoliv vs
Vara
Vara Germany

Making data-driven breast cancer screening accessible to everyone; deeptech with a measurable impact...

56 employees
AI, Health Care
Echoliv vs
ENDRA Life Sciences (Nasdaq: NDRA)
ENDRA Life Sciences (Nasdaq: NDRA) United States

Focused on early detection of liver disease

Post-IPO Equity
25 employees
Biotechnology, Health Care
View all alternatives

FAQ About Echoliv

Crafting AI-driven solutions for abdominal ultrasound, providing early-stage screening to detect liver cancer and other nodules often missed by practitioners.
Echoliv was founded in 2021.
Echoliv operates in AI, Biotechnology and Health Care. Its work centres on AI-driven solutions, abdominal ultrasound imaging, early-stage screening and liver cancer detection.
Echoliv has approximately 2-10 employees.
Echoliv has completed 2 funding rounds, raising a total of $150.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Echoliv include AILIS Care, Vara, ENDRA Life Sciences (Nasdaq: NDRA), Ezra, The Blue Box Biomedical Solutions. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Echoliv and AILIS Care are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Echoliv, https://bouncewatch.com/company/echoliv, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes